IDNA vs. SOXX
IDNA (iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund) and SOXX (iShares Semiconductor ETF) are both exchange-traded funds - IDNA is a Health & Biotech Equities fund tracking the NYSE FactSet Global Genomics and Immuno Biopharma Index, while SOXX is a Semiconductors fund tracking the NYSE Semiconductor Index. Both are passively managed. Over the past 5 years, IDNA returned -8.26%/yr vs 34.67%/yr for SOXX. A 0.52 correlation means they provide meaningful diversification when combined. IDNA charges 0.47%/yr vs 0.34%/yr for SOXX.
Performance
IDNA vs. SOXX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, IDNA achieves a 9.51% return, which is significantly lower than SOXX's 101.03% return.
IDNA
- 1D
- -2.18%
- 1M
- -2.18%
- YTD
- 9.51%
- 6M
- 10.53%
- 1Y
- 41.74%
- 3Y*
- 6.48%
- 5Y*
- -8.26%
- 10Y*
- —
SOXX
- 1D
- 5.79%
- 1M
- 29.90%
- YTD
- 101.03%
- 6M
- 100.20%
- 1Y
- 192.69%
- 3Y*
- 56.47%
- 5Y*
- 34.67%
- 10Y*
- 35.56%
IDNA vs. SOXX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
IDNA iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund | 9.51% | 17.26% | -0.72% | -7.63% | -42.28% | -3.98% | 54.30% | 20.83% |
SOXX iShares Semiconductor ETF | 101.03% | 40.74% | 12.92% | 67.12% | -35.09% | 44.09% | 52.72% | 33.94% |
Correlation
The correlation between IDNA and SOXX is 0.41, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.41 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.43 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.50 |
Correlation (All Time) Calculated using the full available price history since Jun 14, 2019 | 0.52 |
The correlation between IDNA and SOXX shifts across timeframes, from 0.41 (1 year) to 0.52 (all time), reflecting how their relationship changes across market environments.
IDNA vs. SOXX - Sectors Allocation Comparison
Sectors
IDNA
SOXX
Healthcare
-
Industrials
-
Basic Materials
-
-
Communication Services
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
-
Energy
-
-
Financial Services
-
-
Real Estate
-
-
Technology
-
Utilities
-
-
Healthcare
IDNA
SOXX
-
Industrials
IDNA
SOXX
-
Basic Materials
IDNA
-
SOXX
-
Communication Services
IDNA
-
SOXX
-
Consumer Cyclical
IDNA
-
SOXX
-
Consumer Defensive
IDNA
-
SOXX
-
Energy
IDNA
-
SOXX
-
Financial Services
IDNA
-
SOXX
-
Real Estate
IDNA
-
SOXX
-
Technology
IDNA
-
SOXX
Utilities
IDNA
-
SOXX
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
IDNA vs. SOXX — Risk / Return Rank
IDNA
SOXX
IDNA vs. SOXX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund (IDNA) and iShares Semiconductor ETF (SOXX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| IDNA | SOXX | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.71 | 5.68 | -3.97 |
Sortino ratioReturn per unit of downside risk | 2.48 | 5.40 | -2.92 |
Omega ratioGain probability vs. loss probability | 1.28 | 1.75 | -0.47 |
Calmar ratioReturn relative to maximum drawdown | 4.09 | 12.50 | -8.41 |
Martin ratioReturn relative to average drawdown | 11.79 | 47.94 | -36.15 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| IDNA | SOXX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.71 | 5.68 | -3.97 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.29 | 0.97 | -1.26 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 1.07 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.10 | 0.45 | -0.35 |
Drawdowns
IDNA vs. SOXX - Drawdown Comparison
The maximum IDNA drawdown since its inception was -68.26%, roughly equal to the maximum SOXX drawdown of -70.21%. Use the drawdown chart below to compare losses from any high point for IDNA and SOXX.
Loading charts...
Drawdown Indicators
| IDNA | SOXX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -68.26% | -70.21% | +1.95% |
Max Drawdown (1Y)Largest decline over 1 year | -10.66% | -15.77% | +5.11% |
Max Drawdown (3Y)Largest decline over 3 years | -29.73% | -41.36% | +11.63% |
Max Drawdown (5Y)Largest decline over 5 years | -68.26% | -45.75% | -22.51% |
Max Drawdown (10Y)Largest decline over 10 years | — | -45.75% | — |
Current DrawdownCurrent decline from peak | -46.01% | 0.00% | -46.01% |
Average DrawdownAverage peak-to-trough decline | -36.24% | -19.97% | -16.27% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.70% | 4.11% | -0.41% |
Volatility
IDNA vs. SOXX - Volatility Comparison
The current volatility for iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund (IDNA) is 7.24%, while iShares Semiconductor ETF (SOXX) has a volatility of 14.19%. This indicates that IDNA experiences smaller price fluctuations and is considered to be less risky than SOXX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| IDNA | SOXX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.24% | 14.19% | -6.95% |
Volatility (6M)Calculated over the trailing 6-month period | 18.21% | 27.33% | -9.12% |
Volatility (1Y)Calculated over the trailing 1-year period | 24.51% | 34.17% | -9.66% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 28.42% | 36.11% | -7.69% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 29.53% | 33.43% | -3.90% |
IDNA vs. SOXX - Expense Ratio Comparison
IDNA has a 0.47% expense ratio, which is higher than SOXX's 0.34% expense ratio.
Dividends
IDNA vs. SOXX - Dividend Comparison
IDNA's dividend yield for the trailing twelve months is around 1.08%, more than SOXX's 0.28% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
IDNA iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund | 1.08% | 1.18% | 0.98% | 1.04% | 0.54% | 0.70% | 0.26% | 0.80% | 0.00% | 0.00% | 0.00% | 0.00% |
SOXX iShares Semiconductor ETF | 0.28% | 0.57% | 0.67% | 0.78% | 1.26% | 0.64% | 0.81% | 1.23% | 1.37% | 0.90% | 1.08% | 1.29% |
Frequently Asked Questions
IDNA and SOXX have a correlation of 0.41, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
SOXX has higher volatility (14.19%) compared to IDNA (7.24%). In terms of maximum drawdown, IDNA dropped -68.26% vs SOXX's -70.21%.
On 5-year performance, SOXX leads with 34.67% vs -8.26% for IDNA. On fees, SOXX is cheaper at 0.34% per year. On volatility, IDNA has been the lower-risk option at 7.24%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 5-year period, SOXX has performed better with a 34.67% return vs -8.26%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
SOXX is cheaper with a 0.34% expense ratio, compared with 0.47% for IDNA.
IDNA has the higher dividend yield at 1.08%, compared with 0.28% for SOXX.
IDNA is categorized as Health & Biotech Equities, while SOXX is Semiconductors. IDNA tracks NYSE FactSet Global Genomics and Immuno Biopharma Index, while SOXX tracks NYSE Semiconductor Index. Their fees differ too: 0.47% for IDNA and 0.34% for SOXX.
SOXX currently has the higher Sharpe Ratio (5.68 vs 1.71), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for IDNA and SOXX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer